Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Individual variation of human sphingosine 1-phosphate receptor 1 coding sequence leads to heterogeneity in receptor function and drug interactions.
Gray matter is targeted in first-attack multiple sclerosis.
Changes in phospholipid composition of the spinal cord in rabbits with allergic encephalomyelitis as an experimental model of multiple sclerosis.
Natalizumab use in pediatric patients with relapsing-remitting multiple sclerosis.
Patterns of Retinal Damage Facilitate Differential Diagnosis between Susac Syndrome and MS.
Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.
A pooled analysis of two phase 3 clinical trials of dalfampridine in patients with multiple sclerosis.
Genome-wide pathway analysis of a genome-wide association study on multiple sclerosis.
Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72.
Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia.
Pregnancy and Multiple Sclerosis (MS): A Beneficial Association. Possible therapeutic application of embryo-specific Pre-implantation Factor (PIF*).
Do positive or negative stressful events predict the development of new brain lesions in people with multiple sclerosis?
Recommendations for diagnosis and management of multiple sclerosis.
A molecular link between the active component of marijuana and Alzheimer's disease pathology.
Immunopathology of multiple sclerosis.
European ancestry predominates in neuromyelitis optica and multiple sclerosis patients from Brazil.
Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study.
Role of the Programmed Death-1 (PD-1) pathway in regulation of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Cognitive impairment in neuro-Behcet's disease and multiple sclerosis: a comparative study.
Targeting IRF4 in autoimmune diseases.
Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseases.
Reductions in neuronal peroxisomes in multiple sclerosis grey matter.
Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS.
Metabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesis.
Magnetic Resonance Spectroscopy Markers of Disease Progression in Multiple Sclerosis.
Pages
« first
‹ previous
…
130
131
132
133
134
135
136
137
138
…
next ›
last »